US20110046064A1 - Methods and compositions using selective ...,https://www.google.com/patents/US20110046064
WO2006096533A2 - Cranial nerve stimulation for treatment of ...,https://www.google.com/patents/WO2006096533A2
US20040058910A1 - Method of treating substance abuse with ...,https://www.google.com/patents/US20040058910
WO2005094801A1 - Use of an nk3 antagonist for the treatment of ...,https://www.google.com/patents/WO2005094801A1
A61K 31 - Medicinal preparations containing organic active ...,http://www.google.com/patents/sitemap/en/Sitemap/A61/A61K/A61K_31_3889.html
"EP1838325A1 - NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f][1 ...",https://www.google.com/patents/EP1838325A1?cl=un
"US7745458B2 - Azabicyclo (3, 1, 0) hexan derivatives useful as ...",https://www.google.com/patents/US7745458
US20130123354A1 - Soluble guanylate cyclase (sgc) modulators ...,https://www.google.com/patents/US20130123354
US20140275115A1 - Polymorphic forms of 1-[4-(5-cyanoindol-3-yl ...,https://www.google.com/patents/US20140275115
EP2205560A1 - Azabicyclo ý3. 1. 0¨hexyl derivatives as modulators ...,https://www.google.com/patents/EP2205560A1
